Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis–Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial

Authors: Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst, Bridget Wagner, Mauro Zucchetto, Ganesh Raghu, Fernando J. Martinez, Jonathan Goldin, Jeffrey Siegel, Christopher P. Denton

Published: 2021-12-01

DOI: 10.1164/rccm.202103-0714oc

Source: Full article

---

Abstract

No abstract found.